Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational discovery platform-ProMIS and Collective Coordinates-to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins. Using this approach, the Company is developing novel antibody therapeutics for AD, ALS and MSA. Its product candidates are PMN310, PMN267, and PMN442. The PMN310 is a monoclonal antibody designed to treat AD by selectively targeting toxic, misfolded oligomers of amyloid-beta. PMN267 product candidate targeting ALS. PMN442 is a drug candidate being developed for MSA designed to selectively target and protect against pathogenic a-syn species.


NDAQ:PMN - Post by User

Comment by Mole101on Jul 11, 2022 11:59am
120 Views
Post# 34815331

RE:RE:Key to Alzheimer’s Lies in Gut Not Brain, Says New Study..

RE:RE:Key to Alzheimer’s Lies in Gut Not Brain, Says New Study..

 

Since you mention that , here you have little reading to do ..

https://www.prnewswire.com/news-releases/precision-medicine-approach-reverses-early-stage-dementia-301581046.html
Precision Medicine Approach Reverses Early-Stage Dementia


NEWS PROVIDED BY

Apollo Health 

Jul 06, 2022, 09:01 ET

 

BURLINGAME, Calif.July 6, 2022 /PRNewswire/ -- Amid repeated failures of drug trials for Alzheimer's disease, a small pilot study using a precision medicine approach has reported the first promising results, improving cognitive scores in over 80% of patients, as published in the Journal of Alzheimer's Disease1. The team of physicians at three different sites achieved improvement in cognitive testing, brain training scores, partner-assessed symptoms, and even MRI measurements of regional brain volumes.


The patients ranged in age from 50 to 76 years and had either mild cognitive impairment (MCI) or early dementia, similar to the patients in recent pharmaceutical trials. However, when it came to treatment, the team took a fundamentally different approach from previous trials: instead of treating with a single drug that may have nothing to do with the underlying drivers of cognitive decline, the physicians sought the root cause contributors to decline by gathering more data — evaluating inflammation; deficiencies of nutrients, hormones and growth factors;  gut and oral microbiomes; leaky gut; metabolic status; sleep apnea; genetic factors such as a tendency to blood clotting; vascular abnormalities; specific pathogens and toxins; and other potential contributory factors. The identified root causes, which were different from patient to patient, were then targeted with a personalized, precision medicine protocol for nine months, leading to unprecedented improvements, including some patients who increased their cognitive scores from the dementia range to normal.



DavidKingCanada wrote:

See what I mean, learn about the Company before investing, Mole101 is an inexperienced newb and has zero skill in actually making money. Pathetic

 

Mole101 wrote:

 

The key to stopping dementia could lie in the gut rather than the brain, new research suggests. Decades of studies from around the world costing billions of pounds have so far failed to uncover a way of tackling the memory-robbing disease. But the gut “represents an alternative target that may be easier to influence with drugs or diet changes”, experts have said.

 

A series of experiments linking the gut to the development of Alzheimer's were presented at the Alzheimer's Research UK 2022 Conference in Brighton on March 1...



https://english.aawsat.com/home/article/3511291/key-alzheimer%E2%80%99s-lies-gut-not-brain-says-new-study





<< Previous
Bullboard Posts
Next >>